title: Association between prostatic resistive index and cardiovascular risk factors in patients with benign prostatic hyperplasia.
abstract: We evaluated the relationship between prostatic resistive index (RI) and cardiovascular system (CVS) risk factors in patients with benign prostatic hyperplasia. The study included 120 patients who were attending our outpatient clinic with lower urinary tract symptoms related to benign prostatic hyperplasia. The clinical, laboratory, anthropometric data, and CVS risk factors (hypertension, diabetes mellitus, metabolic syndrome, history of CVS events, and smoking) of the patients were evaluated regarding the association between prostate RI level by regression analyses. The prostatic RI levels of the patients were measured using power Doppler imaging. In univariate regression analysis, there were statistically significant relationships between prostatic RI levels and the patients' age, International Prostate Symptom Score, hip circumference, fasting blood glucose, prostate specific antigen, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total prostate volume, uroflowmetric maximal flow rate, and all investigated CVS risk factors (p < 0.05). The prostatic RI levels were found to be associated with fasting blood glucose and total prostate volume, and also with CVS risk factors including only metabolic syndrome and cigarette smoking in the multivariate regression analysis. Our results showed that prostatic RI level is significantly related to metabolic syndrome and smoking among the investigated CVS risk factors.
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Mehmet Murat
authors.initials: MM
authors.lastname: Baykam
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey. Electronic address: kaanaktas73@hotmail.com.
authors.forename: Binhan Kagan
authors.initials: BK
authors.lastname: Aktas
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Suleyman
authors.initials: S
authors.lastname: Bulut
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Cuneyt
authors.initials: C
authors.lastname: Ozden
authors.affiliation: Radiology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Tagmac
authors.initials: T
authors.lastname: Deren
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Suleyman
authors.initials: S
authors.lastname: Tagci
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Cevdet Serkan
authors.initials: CS
authors.lastname: Gokkaya
authors.affiliation: Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Ali
authors.initials: A
authors.lastname: Memis
mesh_terms: D002318:Cardiovascular Diseases / Q000196:embryology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology; D011467:Prostate / Q000378:metabolism / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000453:epidemiology* / Q000378:metabolism / Q000473:pathology; D012307:Risk Factors
keywords: Benign prostatic hyperplasia; Cardiovascular system; Doppler ultrasonography; Metabolic X syndrome; Regional blood flows
references.citation: Prostate Cancer Prostatic Dis. 1998 Mar;1(3):157-162
references.pmid: 12496910
references.citation: Int J Urol. 2002 Aug;9(8):427-30
references.pmid: 12225338
references.citation: Med Ultrason. 2014 Sep;16(3):208-13
references.pmid: 25110761
references.citation: J Ultrasound Med. 2007 Jul;26(7):875-83
references.pmid: 17592050
references.citation: Curr Urol Rep. 2011 Aug;12(4):255-60
references.pmid: 21475953
references.citation: Int Braz J Urol. 2014 Mar-Apr;40(2):240-6
references.pmid: 24856492
references.citation: Int Braz J Urol. 2012 Mar-Apr;38(2):250-5; discussion 255-7
references.pmid: 22555031
references.citation: N Engl J Med. 1996 Aug 22;335(8):586-7
references.pmid: 8678937
references.citation: J Clin Ultrasound. 2005 May;33(4):176-80
references.pmid: 15856514
references.citation: Urology. 2011 Feb;77(2):433-7
references.pmid: 21168193
references.citation: Ultrasound Med Biol. 1997;23(9):1305-9
references.pmid: 9428128
references.citation: Prostate. 2003 Sep 15;57(1):57-65
references.pmid: 12886524
references.citation: Behav Res Methods. 2009 Nov;41(4):1149-60
references.pmid: 19897823
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: BJU Int. 2006 Sep;98(3):587-90
references.pmid: 16796699
references.citation: Int J Endocrinol. 2014;2014:329456
references.pmid: 24688539
references.citation: Curr Bladder Dysfunct Rep. 2010 Dec;5(4):212-218
references.pmid: 21475707
references.citation: BJU Int. 2006 Nov;98(5):1038-42
references.pmid: 16879445
references.citation: Urol Clin North Am. 2009 Nov;36(4):403-15, v
references.pmid: 19942041
references.citation: BJU Int. 2015 Jan;115(1):24-31
references.pmid: 24602293
references.citation: Urology. 2010 Jan;75(1):143-7
references.pmid: 19854491
references.citation: Urology. 2012 Feb;79(2):409-14
references.pmid: 22137544
references.citation: Urology. 2013 Sep;82(3):674-9
references.pmid: 23850334
references.citation: Curr Opin Urol. 2010 Jan;20(1):7-12
references.pmid: 19904208
references.citation: Turk J Urol. 2013 Mar;39(1):22-8
references.pmid: 26328073
references.citation: Korean J Urol. 2011 Aug;52(8):507-16
references.pmid: 21927696
references.citation: Prostate Cancer Prostatic Dis. 2012 Sep;15(3):265-72
references.pmid: 22183774
references.citation: Urol Clin North Am. 2006 Aug;33(3):329-37
references.pmid: 16829268
references.citation: J Urol. 2012 Sep;188(3):881-7
references.pmid: 22819411